Patent · US Active

Compositions and methods for treating myelodysplastic syndrome

US8759303B2 · kind B2 · utility

1Cited by

4References

7Claims

0Family size

Assignee

Telik, Inc. · US

Inventors

Gail L. Brown · Irvine, US
Lixin Meng · Cupertino, US

Key dates

Filing date	May 16, 2011
Grant date	Jun 24, 2014
Priority date	—
Expiry date	Mar 11, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention generally relates to compositions and methods for treating myelodysplastic syndrome. In one embodiment, this invention relates to methods for treating myelodysplastic syndrome with ezatiostat or a salt thereof and lenalidomide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.